Endocannabinoids mediate neuron-astrocyte communication

Neuron. 2008 Mar 27;57(6):883-93. doi: 10.1016/j.neuron.2008.01.029.

Abstract

Cannabinoid receptors play key roles in brain function, and cannabinoid effects in brain physiology and drug-related behavior are thought to be mediated by receptors present in neurons. Neuron-astrocyte communication relies on the expression by astrocytes of neurotransmitter receptors. Yet, the expression of cannabinoid receptors by astrocytes in situ and their involvement in the neuron-astrocyte communication remain largely unknown. We show that hippocampal astrocytes express CB1 receptors that upon activation lead to phospholipase C-dependent Ca2+ mobilization from internal stores. These receptors are activated by endocannabinoids released by neurons, increasing astrocyte Ca2+ levels, which stimulate glutamate release that activates NMDA receptors in pyramidal neurons. These results demonstrate the existence of endocannabinoid-mediated neuron-astrocyte communication, revealing that astrocytes are targets of cannabinoids and might therefore participate in the physiology of cannabinoid-related addiction. They also reveal the existence of an endocannabinoid-glutamate signaling pathway where astrocytes serve as a bridge for nonsynaptic interneuronal communication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Animals
  • Animals, Newborn
  • Astrocytes / drug effects
  • Astrocytes / physiology*
  • Astrocytes / radiation effects
  • Calcium / metabolism
  • Cannabinoid Receptor Modulators / pharmacology
  • Cannabinoid Receptor Modulators / physiology*
  • Cell Communication / physiology*
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Electric Stimulation / methods
  • Endocannabinoids*
  • Excitatory Amino Acid Antagonists / pharmacology
  • Glial Fibrillary Acidic Protein / metabolism
  • Glutamic Acid / metabolism
  • Hippocampus / cytology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neurons / drug effects
  • Neurons / physiology*
  • Neurons / radiation effects
  • Patch-Clamp Techniques
  • Photolysis
  • Piperidines / pharmacology
  • Pyrazoles / pharmacology
  • Receptor, Cannabinoid, CB1 / deficiency
  • Receptor, Cannabinoid, CB1 / genetics
  • Receptor, Cannabinoid, CB1 / metabolism
  • Type C Phospholipases / pharmacology
  • Valine / analogs & derivatives
  • Valine / pharmacology

Substances

  • Cannabinoid Receptor Modulators
  • Endocannabinoids
  • Excitatory Amino Acid Antagonists
  • Glial Fibrillary Acidic Protein
  • Piperidines
  • Pyrazoles
  • Receptor, Cannabinoid, CB1
  • AM 251
  • Glutamic Acid
  • Egtazic Acid
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • 2-amino-5-phosphopentanoic acid
  • Type C Phospholipases
  • Valine
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Calcium